- Will Oura's market cap be less than $7.5B at market close on IPO day?8¢
- Will Oura's market cap be between $7.5B and $10B at market close on IPO day?9¢
- Will Oura's market cap be between $10B and $12.5B at market close on IPO day?14¢
- Will Oura's market cap be between $12.5B and $15B at market close on IPO day?11¢
- Will Oura's market cap be between $15B and $17.5B at market close on IPO day?14¢
- Will Oura's market cap be between $17.5B and $20B at market close on IPO day?14¢
- Will Oura's market cap be at least $20B at market close on IPO day?14¢
- Will Oura not IPO before January 2027?12¢
This market will resolve based on Oura's market capitalization at the closing price on its first day of trading. If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day. If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket. Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used. In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Recent Bloomberg reporting that Oura Health is targeting an IPO as soon as September to raise up to $3 billion at a valuation above $16 billion serves as the primary catalyst anchoring trader sentiment. This follows the company’s confidential SEC filing in May and follows its $10.9 billion Series E post-money valuation from September 2025, supported by rapid revenue growth toward an expected $1.5–2 billion run rate in 2026. Competitive pressures from Samsung’s Galaxy Ring and Whoop’s $10 billion valuation, alongside Oura’s differentiation through sensor-driven AI health data and membership expansion, contribute to the closely matched probabilities across the $15–20 billion+ buckets. Market-implied odds around 14 percent each for the leading ranges reflect uncertainty over final pricing, secondary share sales by existing investors, and broader IPO window conditions.